Dr. Frank Ong is the Chief Medical and Scientific Officer at Everlywell, the digital health company poised to disrupt the 25 billion dollar diagnostics industry by providing consumers with at-home lab testing kits that include insightful, easy-to-understand results. Dr. Ong leads the company's laboratory operations, clinical science, and medical affairs departments, including research and development of new tests. Prior to joining Everlywell, Dr. Ong held leadership positions at Guardant Health, Roche Diagnostics, and Illumina and served as a faculty member and researcher at Cedars-Sinai Medical Center, where he received research grants from the National Institutes of Health (NIH). He earned his medical degree from the Keck School of Medicine at the University of Southern California and holds graduate certificates in clinical and translational investigation, biodesign and medical device innovation and clinical trial administration from Stanford University, UCLA and University of California San Diego. He served his residency in the Department of Family Medicine at UCLA’s Geffen School of Medicine. He resides in Austin, Texas.
Health Monitoring Showcase:
Everlywell makes lab testing easy and convenient with at-home collection and digital results in days. Founded in 2015, the company has expanded to offer over 30 panels, including first-to-market tests in fertility, food sensitivity, vitamins, peri and postmenopause, and high-risk HPV.
Consumer Testing And Precision Medicine: Past, Present, And Future
Combining genotypic and phenotypic data to provide tailored healthcare is the vision of precision medicine, yet the testing industry was quicker to bring consumer genomics to market than consumer testing for basic biomarkers such as hormones, vitamins, and markers associated with chronic conditions. This session will discuss the past, present and future of precision medicine using this lens.
The PMWC 2020 Health Monitoring Showcase will provide 15 minute speaking opportunities for selected companies working with the latest technologies in remote patient and care monitoring, providing devices that are smart and integrated with high-touch approaches, sensors, data collection and analytical capabilities translating patient vital signs into useful insights and alert triggers. These companies will share their innovative products to an audience of leading investors, potential clients, and partners. The PMWC 2019 Health Monitoring Showcase will exhibit the latest innovations that lead to products, systems, and services that empower patients with chronic conditions to better understand and self-manage their conditions and provide clinicians with easy, efficient monitoring that enhance patients’ lives and enable the delivery of better outcomes at lower cost.